Data / Form D filings / Imunon, Inc.
Imunon, Inc.: Form D filings
Imunon, Inc., a biotechnology company in Lawrenceville, NJ, filed 6 Form D notices with the SEC between 2010 and 2025. The latest, on May 28, 2025, reports $3.3 million sold of a $3.3 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 997 LENOX DRIVE, SUITE 100, Lawrenceville, NJ, 08648
- Phone
- (609) 896-9100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 749647
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 28, 2025 | New notice | $3,250,001 | $3,250,001 | 3 | May 27, 2025 | sec.gov | |
| Aug 16, 2024 | New notice | $10,000,000 | $10,000,000 | 4 | Aug 1, 2024 | sec.gov | |
| Jun 8, 2015 | New notice | $5,070,000 | $5,070,000 | 3 | Jun 1, 2015 | sec.gov | |
| Jun 24, 2014 | New notice | $8,500,000 | $8,500,000 | 1 | Jun 20, 2014 | sec.gov | |
| Jun 14, 2011 | New notice | $8,580,000 | $8,580,000 | 31 | Jun 2, 2011 | sec.gov | |
| Jul 26, 2010 | New notice | $15,139,744 | $139,744 | $15,000,000 | 1 | Jun 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David H. Gaiero | Executive Officer | |
| James E. Dentzer | Director | |
| Donald P. Braun | Director | |
| Michael H. Tardugno | Executive Officer, Director | |
| Frederick J. Fritz | Director | |
| Stacy R. Lindborg | Executive Officer, Director | |
| Christine J. Pellizzari | Director | |
| Douglas H. Faller | Executive Officer | |
| Susan H. Eylward | Executive Officer | |
| Khursheed H. Anwer | Executive Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of May 26, 2025 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Imunon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.